Search
Search Results
##search.searchResults.foundPlural##
-
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1283PDF: 607HTML: 3095 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
6972PDF: 3921HTML: 24881 -
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
2550PDF: 872HTML: 2123 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1037PDF: 652HTML: 78 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1105PDF: 544HTML: 1690Figures: 167Fifures Sanz: 176tables Sanz: 180Untitled: 176 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3511PDF: 891HTML: 1653figure 1: 165Untitled: 189 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2415PDF: 926HTML: 532 -
DIAGNOSTIC VALUE OF SIMULTANEOUS MEASUREMENT OF PROCALCITONIN, INTERLEUKIN-6 AND HS CRP IN PREDICTION OF EARLY-ONSET NEONATAL SEPSIS
2027PDF: 1206HTML: 1934Untitled: 148TaBles Neinates sepsis: 173 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1463PDF: 1062HTML: 217 -
IDENTİFİCATİON OF LEİSHMANİA TROPİCA FROM PEDİATRİC VİSCERAL LEİSHMANİASİS İN SOUTHERN MEDITERRANEAN REGION OF TURKEY. Molecular characterization of pediatric visceral leishmaniasis
1003PDF: 696HTML: 221 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2783PDF: 1018HTML: 360Preferred Reviewers: 207 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12346PDF: 1681HTML: 4190Cover letter: 199Figure 1: 204 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
3890PDF: 757HTML: 1849 -
CAN WE PREDICT INCIPIENT DIABETES MELLITUS IN PATIENTS WITH TRANSFUSION DEPENDENT β-THALASSEMIA (β-TDT) REFERRED WITH A HISTORY OF PREDIABETES? Risk factors for incipient diabetes in thalassemia
1048PDF: 1339HTML: 107 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3201PDF: 781HTML: 2956Figure 1a and 1b: 149Figure 2: 159Figure 3: 177Figure 4: 159Figure 5: 163Tables 1-5: 151 -
ADVERSE PREGNANCY OUTCOMES IN SICKLE CELL TRAIT: A PROSPECTIVE COHORT STUDY EVALUATING CLINICAL AND HAEMATOLOGICAL PARAMETERS IN POSTPARTUM MOTHERS AND NEW-BORNS. Sickle cell trait pregnancy and outcomes
1375PDF: 1217HTML: 482 -
HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation
1124PDF: 778HTML: 208 -
DISTRIBUTION OF DIFFERENT PML/RAR? BCR ISOFORMS IN INDIAN ACUTE PROMYELOCYTIC LEUKAEMIA (APL) PATIENTS AND CLINICOHEMATOLOGICAL CORRELATION
1454PDF: 906HTML: 2212Response to reviewers comments: 180 -
Respiratory function in pediatric African SCA patients underwent bone marrow transplantation
2123PDF: 759HTML: 1050Spirometry in SCA patients before transplant: 200Spirometry in SCA patients post transplant: 180 -
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
10616PDF: 6368HTML: 21786 -
PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.
2519PDF: 1189HTML: 11799 -
The association of rheumatoid arthritis with glucose- 6-phosphate dehydrogenase deficiency—results from a case-control study. G6PD and Rheumatoid Arthritis
1078PDF: 842HTML: 105 -
COULD PLASMA GLUCOSE (PG) INCREMENT (PG %) EXPAND THE CLINICAL WEIGHT OF OGTT? PRELIMINARY FINDINGS IN 19 TDT PATIENTS (Β-TDT) WITH NORMAL GLUCOSE TOLERANCE Plasma glucose (PG) increment (PG %) and pancretic β-cell dysfunction in thalassemia
715PDF: 497HTML: 43 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3059PDF: 877HTML: 7164Kost Fig1: 183Kost Fig 2: 179Kost Fig3: 176Kost Fig 4: 190Kost Fig5: 185Kost fig 6: 173







